AVITA Medical (RCEL) Asset Utilization Ratio (2020 - 2025)
AVITA Medical (RCEL) posted Asset Utilization Ratio of 2.42 for Q4 2025, up 106.39% on a QoQ basis from 1.17 in Q3 2025, and up 204.66% year-over-year from 0.79 in Q4 2024.
AVITA Medical (RCEL) Asset Utilization Ratio (2020 - 2025) Analysis & Trends
AVITA Medical's Asset Utilization Ratio history runs 6 years deep, the most recent figure standing at 2.42 for Q4 2025.
- Quarterly Asset Utilization Ratio rose 204.66% year-over-year to 2.42 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 2.42 (up 204.66% YoY) and the FY2025 annual result came in at 1.05, up 57.57% from the prior year.
- Asset Utilization Ratio was 2.42 for Q4 2025 at AVITA Medical, up from 1.17 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 2.42 in Q4 2025 and bottomed at 0.23 in Q1 2021.
- A 5-year average of 0.72 and a median of 0.55 in 2022 frame the typical range for Asset Utilization Ratio.
- Annual changes were most pronounced in 2023 — Asset Utilization Ratio sank 30.52% — and 2025, when it jumped 204.66%.
- AVITA Medical's Asset Utilization Ratio stood at 0.48 in 2021, then climbed by 10.01% to 0.53 in 2022, then retreated by 1.13% to 0.52 in 2023, then surged by 52.7% to 0.79 in 2024, then soared by 204.66% to 2.42 in 2025.
- Business Quant data shows RCEL's Asset Utilization Ratio at 2.42 in Q4 2025, 1.17 in Q3 2025, and 1.16 in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.46 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 0.54 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 0.39 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 0.47 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 0.47 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 0.74 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 0.65 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 0.57 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | AVITA Medical | 140.94 Mn | 124.59 Mn | 14.31 Mn | 2.42 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.42 |
| Sep 30, 2025 | 1.17 |
| Jun 30, 2025 | 1.16 |
| Mar 31, 2025 | 0.95 |
| Dec 31, 2024 | 0.79 |
| Sep 30, 2024 | 0.71 |
| Jun 30, 2024 | 0.58 |
| Mar 31, 2024 | 0.49 |
| Dec 31, 2023 | 0.52 |
| Sep 30, 2023 | 0.54 |
| Jun 30, 2023 | 0.46 |
| Mar 31, 2023 | 0.38 |
| Dec 31, 2022 | 0.53 |
| Sep 30, 2022 | 0.61 |
| Mar 31, 2022 | 0.55 |
| Sep 30, 2021 | 0.48 |
| Jun 30, 2021 | 0.30 |
| Mar 31, 2021 | 0.23 |
| Dec 31, 2020 | 0.25 |
| Sep 30, 2020 | 0.20 |